AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
187.25
-8.82 (-4.50%)
May 6, 2025, 2:57 PM EDT - Market open
AbbVie Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for AbbVie stock have an average target of 212, with a low estimate of 185 and a high estimate of 250. The average target predicts an increase of 13.22% from the current stock price of 187.25.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 23 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 8 | 8 | 8 |
| Buy | 11 | 11 | 11 | 10 | 10 | 11 |
| Hold | 2 | 3 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 21 | 21 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $214 → $216 | Strong Buy | Maintains | $214 → $216 | +15.35% | Apr 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $204 → $205 | Buy | Maintains | $204 → $205 | +9.48% | Apr 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $241 → $250 | Buy | Maintains | $241 → $250 | +33.51% | Apr 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $210 | Buy | Initiates | $210 | +12.15% | Apr 22, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $214 | Strong Buy | Reiterates | $214 | +14.29% | Apr 17, 2025 |
Financial Forecast
Revenue This Year
60.72B
from 56.33B
Increased by 7.79%
Revenue Next Year
65.53B
from 60.72B
Increased by 7.92%
EPS This Year
12.46
from 2.39
Increased by 421.27%
EPS Next Year
14.18
from 12.46
Increased by 13.79%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 63.6B | 70.0B | 75.0B | ||
| Avg | 60.7B | 65.5B | 69.9B | ||
| Low | 57.5B | 60.4B | 64.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.9% | 15.2% | 14.4% | ||
| Avg | 7.8% | 7.9% | 6.7% | ||
| Low | 2.1% | -0.5% | -1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.23 | 15.81 | 18.01 | ||
| Avg | 12.46 | 14.18 | 15.65 | ||
| Low | 11.77 | 12.58 | 13.54 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 453.6% | 26.9% | 27.0% | ||
| Avg | 421.3% | 13.8% | 10.4% | ||
| Low | 392.5% | 1.0% | -4.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.